SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10459906
Source:
http://linkedlifedata.com/resource/pubmed/id/10459906
Search
Subject
(
62
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026926
,
umls-concept:C0041296
,
umls-concept:C0087111
,
umls-concept:C0392751
pubmed:issue
9157
pubmed:dateCreated
1999-9-7
pubmed:abstractText
We assessed a programme of tuberculosis control in a prison setting in Baku, Azerbaijan. The programme used first-line therapy and DOTS (directly observed treatment, short course).
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2985213R
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antibiotics, Antitubercular
,
http://linkedlifedata.com/resource/pubmed/chemical/Antitubercular Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Ethambutol
,
http://linkedlifedata.com/resource/pubmed/chemical/Isoniazid
,
http://linkedlifedata.com/resource/pubmed/chemical/Rifampin
,
http://linkedlifedata.com/resource/pubmed/chemical/Streptomycin
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0140-6736
pubmed:author
pubmed-author:ConinxRR
,
pubmed-author:DebackerMM
,
pubmed-author:IsmaelovAA
,
pubmed-author:MathieuCC
,
pubmed-author:MeddingsD RDR
,
pubmed-author:MirzoevFF
,
pubmed-author:de HallerRR
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
353
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
969-73
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:10459906-Adult
,
pubmed-meshheading:10459906-Antibiotics, Antitubercular
,
pubmed-meshheading:10459906-Antitubercular Agents
,
pubmed-meshheading:10459906-Azerbaijan
,
pubmed-meshheading:10459906-Dietary Supplements
,
pubmed-meshheading:10459906-Ethambutol
,
pubmed-meshheading:10459906-Humans
,
pubmed-meshheading:10459906-Isoniazid
,
pubmed-meshheading:10459906-Logistic Models
,
pubmed-meshheading:10459906-Male
,
pubmed-meshheading:10459906-Mycobacterium tuberculosis
,
pubmed-meshheading:10459906-Patient Compliance
,
pubmed-meshheading:10459906-Pilot Projects
,
pubmed-meshheading:10459906-Prisoners
,
pubmed-meshheading:10459906-Prisons
,
pubmed-meshheading:10459906-Rifampin
,
pubmed-meshheading:10459906-Sputum
,
pubmed-meshheading:10459906-Streptomycin
,
pubmed-meshheading:10459906-Survival Rate
,
pubmed-meshheading:10459906-Treatment Failure
,
pubmed-meshheading:10459906-Treatment Outcome
,
pubmed-meshheading:10459906-Tuberculosis, Multidrug-Resistant
,
pubmed-meshheading:10459906-Tuberculosis, Pulmonary
,
pubmed-meshheading:10459906-World Health Organization
pubmed:year
1999
pubmed:articleTitle
First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
pubmed:affiliation
International Committee of the Red Cross, Geneva, Switzerland. rconinx@icrc.org
pubmed:publicationType
Journal Article